Restructuring Activities (Tables)

The following tables summarize the Company’s restructuring activities for the years ended December 31, 2011, 2010 and 2009:



	Year Ended December 31, 2011
	Energy & Chemicals			Distribution & Storage			BioMedical			Corporate			Total
Balance as of January 1, 2011	$	103		$	387		$	2,088		$	—		$	2,578
Restructuring charges	—			315			4,940			437			5,692
Asset impairment	—			—			(1,218		)	—			(1,218		)
Cash payments	(103		)	(587		)	(4,812		)	(437		)	(5,939		)
Balance as of December 31, 2011	$	—		$	115		$	998		$	—		$	1,113



	Year Ended December 31, 2010
	Energy & Chemicals			Distribution & Storage			BioMedical			Corporate			Total
Balance as of January 1, 2010	$	682		$	1,608		$	503		$	88		$	2,881
Restructuring charges	—			(45		)	4,723			78			4,756
Asset impairment	—			—			(1,546		)	(100		)	(1,646		)
Cash payments	(579		)	(1,176		)	(1,592		)	(66		)	(3,413		)
Balance as of December 31, 2010	$	103		$	387		$	2,088		$	—		$	2,578



	Year Ended December 31, 2009
	Energy & Chemicals			Distribution & Storage			BioMedical			Corporate			Total
Balance as of January 1, 2009	$	—		$	—		$	—		$	—		$	—
Restructuring charges	1,004			3,397			3,336			283			8,020
Asset impairment	—			(234		)	(996		)	—			(1,230		)
Cash payments	(322		)	(1,555		)	(1,837		)	(195		)	(3,909		)
Balance as of December 31, 2009	$	682		$	1,608		$	503		$	88		$	2,881

- Definition

Tabular disclosure of restructuring and related costs by type of restructuring including the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost.

+ References+ Details